Drug trial for advanced solid tumors that stopped responding
Treatments studied
Part of Cancer clinical trials.
This early-stage study tests an investigational drug (MHB088C) in adults with advanced or metastatic solid cancers that have gotten worse or can’t be treated with standard options. It aims to see if the drug is safe and can shrink tumors or control the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older and able to sign informed consent
- Have advanced or metastatic solid cancer that cannot be fully removed with surgery and has progressed on standard treatment (or no standard options exist)
- Be generally well enough for study treatment (ECOG performance score 0–1) and expect to live at least 3 months
- If you can become pregnant or father a child, use highly reliable birth control during the study and for at least 90 days after the last dose
- Have at least one measurable tumor spot on scans (some previously treated brain areas may still qualify under strict conditions)
- Have adequate blood counts and organ function (bone marrow, liver, kidneys, heart) based on blood tests and heart scan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1/2 trial tests MHB036C in people with advanced or metastatic solid cancers that have stopped responding to standard treatments (or no standard options exist). It is meant to see how the drug works and how safe it is in this group.
This trial tests an experimental drug for people with advanced solid tumors, including small cell lung cancer, that have stopped responding to standard treatments. The goal is to find out if the drug is safe and effective.
This trial tests an experimental drug called MHB046C for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it can shrink tumors or slow their growth.
This trial tests a combination of two experimental drugs, MHB088C and MHB039A, for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if this combination can shrink tumors and help patients live longer.
This trial tests a combination of two investigational drugs, MHB036C and MHB039A, in people with advanced breast cancer or other solid tumors that have spread. The goal is to see if this combination can shrink tumors and help patients live longer.
This trial tests a new drug called MHB009C for people with advanced solid tumors that have not responded to other treatments. The goal is to see if the drug is safe and effective.
Hear when a new Advanced or Metastatic Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.